A Comparison Between Deep Sclerectomy and Trabeculectomy
Deep Sclerectomy Versus Trabeculectomy. A 7 Year Prospective Randomised Clinical Trial
1 other identifier
interventional
70
1 country
1
Brief Summary
Patients affected by medically uncontrolled open angle glaucoma will be randomised to either a non penetrating procedure (deep sclerectomy) or conventional trabeculectomy. The longterm efficacy (i.e. IOP w/out therapy) and safety (i.e. visual acuity, visual field stability and co-morbidities) will be evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 1997
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 1997
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2007
CompletedFirst Submitted
Initial submission to the registry
January 7, 2008
CompletedFirst Posted
Study publicly available on registry
January 16, 2008
CompletedJanuary 16, 2008
January 1, 2008
9.3 years
January 7, 2008
January 7, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
intra ocular pressure without therapy (% of eyes within pre-selected cut-off limits)
7 years
Secondary Outcomes (1)
(a) LogMAR visual acuity, (b) number of cataract extraction procedures
7 years
Study Arms (2)
TE
ACTIVE COMPARATORtrabeculectomy
DS
EXPERIMENTALdeep sclerectomy
Interventions
Cairns-like trabeculectomy, limbus based, with 5\_FU supplementation and argon laser suturelysis
deep sclerectomy with no implant and no sutures to the superficial flap, limbus based with suppplementation of FU (if needed)
Eligibility Criteria
You may qualify if:
- Angle wide open
- Age \> 65 yrs
- IOP \> 23 and \< 30 mmHg (average of the two highest readings of the daily IOP phasing)
- Topical beta blocker in fellow eye
- At least two medications in use + previous ALT
- MD \< 20 dB (HFA 24-2 full threshold)
- LOCSII \< C1-N1-P0
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sally Williams
Parma, 43100, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gandolfi Stefano, MD
University of Parma
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 7, 2008
First Posted
January 16, 2008
Study Start
October 1, 1997
Primary Completion
January 1, 2007
Study Completion
December 1, 2006
Last Updated
January 16, 2008
Record last verified: 2008-01